December 19, 2025

Semler Scientific, Inc. (SMLR) Investor Outlook: Unlocking a 283.79% Potential Upside in the Medical Devices Sector

Semler Scientific, Inc. (NASDAQ: SMLR), a key player in the healthcare sector, specifically within the medical devices industry, is garnering attention for its innovative technology solutions..

InMode Ltd. (INMD) Stock Analysis: Navigating the Healthcare Sector with a 14% Potential Upside

InMode Ltd. (NASDAQ: INMD), a prominent player in the healthcare sector specializing in medical devices, commands attention with its innovative minimally invasive aesthetic solutions. Headquartered in..

Bioventus Inc. (BVS) Stock Analysis: Unveiling a Near 95% Upside Potential in the Medical Device Sector

Bioventus Inc. (NASDAQ: BVS), a company at the forefront of medical innovations in the healthcare sector, presents a compelling investment case for those looking to capitalize..

Trevi Therapeutics, Inc. (TRVI) Stock Analysis: Exploring a 72% Potential Upside with Strong Buy Ratings

Trevi Therapeutics, Inc. (NASDAQ: TRVI), a pioneering clinical-stage biopharmaceutical company, has drawn considerable attention from investors, bolstered by an impressive 72.27% potential upside and unanimous buy..

LENZ Therapeutics, Inc. (LENZ) Stock Analysis: Unpacking the 214.67% Potential Upside in Biotech Vision Solutions

LENZ Therapeutics, Inc. (LENZ), a promising player in the biotechnology industry, has captured investor attention with its significant potential upside of 214.67%. Focused on developing therapies..

Stoke Therapeutics, Inc. (STOK) Stock Analysis: A Promising Biotech with 117% Revenue Growth and Strong Buy Ratings

Stoke Therapeutics, Inc. (NASDAQ: STOK) has captured the attention of investors with its innovative approach to treating genetic diseases and recent financial performance. As a biotechnology..

Arbutus Biopharma (ABUS) Stock Analysis: Exploring a 25.5% Potential Upside in the Biotechnology Sector

Arbutus Biopharma Corporation (NASDAQ: ABUS) stands out in the biotechnology sector, a field known for its dynamic and high-risk, high-reward nature. With a market capitalization of..

AxoGen, Inc. (AXGN) Stock Analysis: Analysts See 11.81% Upside in Innovative Nerve Repair Solutions

AxoGen, Inc. (NASDAQ: AXGN), a pioneering force in the medical devices sector, particularly in the niche of peripheral nerve regeneration and repair, has been capturing the..

EyePoint Pharmaceuticals (EYPT): Analyst Ratings Signal a Promising 108% Upside

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a key player in the biotechnology sector, is capturing investor attention with its groundbreaking approach to tackling severe retinal diseases. With..

Anavex Life Sciences Corp. (AVXL) Stock Analysis: Exploring a 465% Potential Upside in Biotech

Anavex Life Sciences Corp. (NASDAQ: AVXL), a prominent player in the biotechnology sector, is grabbing investor attention with its staggering potential upside of 465.55%. Specializing in..

PureTech Health plc (PRTC): A Biotech Contender with Explosive Revenue Growth and Strategic Innovations

In the dynamic world of biotechnology, PureTech Health plc (NASDAQ: PRTC) distinguishes itself not only with its innovative pipeline but also with an astounding revenue growth..

Cross Country Healthcare, Inc. (CCRN): Investor Outlook with a 20.33% Potential Upside

Cross Country Healthcare, Inc. (NASDAQ: CCRN), a key player in the healthcare staffing industry, presents an interesting proposition for investors looking to navigate the complexities of..

Oculis Holding AG (OCS) Stock Report: Exploring a Potential 130.80% Upside in Ophthalmic Innovation

Oculis Holding AG (NASDAQ: OCS), a Swiss-based biotechnology company at the forefront of ophthalmic innovation, has been capturing the attention of investors due to its promising..

COMPASS Pathways Plc (CMPS): Investor Outlook with a 170% Upside Potential in the Mental Health Sector

COMPASS Pathways Plc (NASDAQ: CMPS) presents an intriguing opportunity for investors seeking exposure to the burgeoning mental health treatment sector. With its focus on innovative psilocybin..

Auna SA (AUNA) Stock Analysis: Exploring a 126% Potential Upside in the Healthcare Sector

Auna SA (AUNA), a prominent player in the healthcare sector, has captured investor attention with its significant potential upside. Headquartered in Luxembourg, this medical care facilities..

Day One Biopharmaceuticals, Inc (DAWN) Stock Analysis: Exploring a 123% Potential Upside for Investors

Day One Biopharmaceuticals, Inc (NASDAQ: DAWN), a pioneering entity in the biotechnology sector, is capturing investor interest with its promising pipeline of treatments for pediatric and..

MeiraGTx Holdings (MGTX) Stock Analysis: Unveiling a 237% Potential Upside Opportunity

MeiraGTx Holdings plc (NASDAQ: MGTX), a clinical-stage genetic medicines company, is drawing significant attention from investors with an eye for high-growth opportunities in the healthcare sector...

Tectonic Therapeutic, Inc. (TECX) Stock Report: Analyst Consensus Points to a Potential 328% Upside

For investors with an eye on revolutionary biotechnology companies, Tectonic Therapeutic, Inc. (NASDAQ: TECX) is a promising player with significant upside potential. The company’s innovative approach..

SIGA Technologies Inc. (SIGA) Stock Report: A Closer Look at Its Strong Return on Equity Amidst Revenue Decline

For individual investors keen on the healthcare sector, SIGA Technologies Inc. (SIGA) presents a unique case study. Operating in the niche market of pharmaceutical products focused..

Claritev Corporation (CTEV) Stock Analysis: Unpacking a 106.76% Potential Upside in the Healthcare Sector

Claritev Corporation (CTEV), a key player in the healthcare industry, is making waves with a staggering potential upside of 106.76% based on analyst target prices. Specializing..

Search

Funds

December 19, 2025

Search

Funds

December 19, 2025

FTSE 100

Funds